作者: Luigi Sereno
DOI: 10.2139/SSRN.1547185
关键词: Corporate finance 、 Valuation (finance) 、 Real options valuation 、 Actuarial science 、 Pharmaceutical industry 、 Patent valuation 、 Economic valuation 、 Business 、 Drug development
摘要: This study sets up a real options approach for evaluating patents as to develop and commercialize new medicines. We provide case in patent evaluation, i.e. ROV-based DCF computing the value of an oncological drug patent. The option relies on well-established compound method extensively used by academics corporate finance practitioners deal with valuation early-stage R&D projects. show that model can be practically underlying development project thus evaluate using much possible data provided one largest oncology-focused companies Europe. apply continuous-time lattice order find this Since it shows how has straightforward practical usefulness. topic is mainly suggested critical unresolved question concerning economic patents.